Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiji Shitara

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Indian Journal of Pediatrics|December 3, 2003
Current treatment and future directions in neuroblastomaYoshiaki Tsuchida, Toshiji Shitara, Minoru Kuroiwa, et al.
Pediatric Blood & Cancer|September 19, 2008
How can we ameliorate irinotecan-associated diarrhea in children with poor compliance for oral cephalosporin?Hiroki Nariai, Toshiji Shitara, Yuji Oto, et al.
Medical and Pediatric Oncology|December 4, 2002
Successful clinical response to irinotecan in relapsed neuroblastomaToshiji Shitara, Akira Shimada, Yoshiaki Tsuchida, et al.
Pediatric Blood & Cancer|June 2, 2005
Histologic survey of neuroblastomas after intensive induction chemotherapyYoshiaki Tsuchida, Jun Miyauchi, Minoru Kuroiwa, et al.
Journal of Pediatric Surgery|December 25, 2003
An infant with systemic hypertension, renal artery stenosis, and neuroblastomaMakoto Shinohara, Toshiji Shitara, Shin-itsu Hatakeyama, et al.
Pediatric Surgery International|April 19, 2005
Pulmonary metastases after nephrectomy only for small, stage I/favorable-histology Wilms' tumorToshiji Shitara, Yoshiaki Tsuchida, Junko Hirato, et al.
Journal of Pediatric Surgery|November 18, 2005
Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRAMinoru Kuroiwa, Mitsuteru Hiwatari, Junko Hirato, et al.
Pediatric Hematology and Oncology|May 3, 2006
Irinotecan for children with relapsed solid tumorsToshiji Shitara, Akira Shimada, Ryoji Hanada, et al.
Biology of the Neonate|December 13, 2003
Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndromeAkira Shimada, Kenichi Maruyama, Toshiji Shitara, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Indian Journal of Pediatrics|December 3, 2003
Current treatment and future directions in neuroblastomaYoshiaki Tsuchida, Toshiji Shitara, Minoru Kuroiwa, et al.
Pediatric Blood & Cancer|September 19, 2008
How can we ameliorate irinotecan-associated diarrhea in children with poor compliance for oral cephalosporin?Hiroki Nariai, Toshiji Shitara, Yuji Oto, et al.
Medical and Pediatric Oncology|December 4, 2002
Successful clinical response to irinotecan in relapsed neuroblastomaToshiji Shitara, Akira Shimada, Yoshiaki Tsuchida, et al.
Pediatric Blood & Cancer|June 2, 2005
Histologic survey of neuroblastomas after intensive induction chemotherapyYoshiaki Tsuchida, Jun Miyauchi, Minoru Kuroiwa, et al.
Journal of Pediatric Surgery|December 25, 2003
An infant with systemic hypertension, renal artery stenosis, and neuroblastomaMakoto Shinohara, Toshiji Shitara, Shin-itsu Hatakeyama, et al.
Pediatric Surgery International|April 19, 2005
Pulmonary metastases after nephrectomy only for small, stage I/favorable-histology Wilms' tumorToshiji Shitara, Yoshiaki Tsuchida, Junko Hirato, et al.
Journal of Pediatric Surgery|November 18, 2005
Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRAMinoru Kuroiwa, Mitsuteru Hiwatari, Junko Hirato, et al.
Pediatric Hematology and Oncology|May 3, 2006
Irinotecan for children with relapsed solid tumorsToshiji Shitara, Akira Shimada, Ryoji Hanada, et al.
Biology of the Neonate|December 13, 2003
Proinflammatory cytokinemia associated with transient myeloproliferative disorder in down syndromeAkira Shimada, Kenichi Maruyama, Toshiji Shitara, et al.
Pageof 1